Adenovirus Vaccines

Live oral vaccine for adenovirus types 4 and 7 (military use)

This page catalogs 1 adenovirus vaccine product. The Adenovirus Type 4 and 7 vaccine is unique among US-licensed vaccines in being restricted to military use, addressing acute respiratory disease outbreaks that historically affected military training facilities. Production was interrupted from 1999 to 2011, during which adenovirus outbreaks resumed among recruits.

Last updated: April 2026.

Adenovirus Vaccine Catalog

Trade Name Generic Designation Manufacturer Vaccine Type Regulatory Status & Year Key Notes
Adenovirus Type 4 and 7 Vaccine Adenovirus Type 4 and Type 7 vaccine, live oral Teva (Barr) Live oral FDA Licensed, 2011 Military use only

Sources

Regulatory data sourced from FDA CBER Vaccines Licensed for Use in the United States (March 2026). Catalog scope informed by Khan, Shaz, The Ultimate Vaccine Timeline.

Related Pages on VaccinationFacts.com

Vaccine Catalog

Browse all vaccine categories

Anthrax Vaccines

Biodefense vaccine products

Vaccine History Timeline

Milestones in vaccine development